Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alitretinoin vs PUVA as first-line treatment for severe chronic hand eczema
2014-004741-27Phase 4Unknown
- Sponsor
- University of Leeds
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic hand dermatitis (CHE) and atopic dermatitis (AD) comparing Alitretinoin with PUVA (2 arms). Primary endpoint: Primary: Log(HECSI score) at 12 weeks. Status: unknown.
02
Drugs
alitretinoinmethoxsalen
03
Conditions
chronic hand dermatitis (CHE)atopic dermatitis (AD)
Beyond the preview
Go deeper on 2014-004741-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004741-27.